Lord Abbett

Lord Abbett & Co. LLC is an employee-owned investment manager based in Jersey City, New Jersey, founded in 1929. The firm offers a range of investment services primarily to individuals, including high net worth clients, as well as to institutional clients such as pension plans, corporations, and charitable organizations. Lord Abbett manages client-focused equity, fixed income, and balanced portfolios, and it also launches and manages various mutual funds across asset classes. The firm invests in public equity and fixed income markets globally, with a particular emphasis on the United States and emerging markets. Its equity investments span growth, value, and dividend-paying stocks of varying market capitalizations, while its fixed income strategy includes municipal bonds, corporate securities, government securities, and high-yield securities. The firm utilizes both quantitative and fundamental analysis to inform its investment decisions, leveraging external research alongside its in-house expertise to enhance portfolio performance.

Emanuela Scura

Partner, Chief Sustainability Officer and Member of the Global Corporate Citizenship and Investment Committee

1 past transactions

Coherus Biosciences

Post in 2020
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company based in Redwood City, California, that specializes in the development, manufacture, and marketing of biosimilar therapeutics. It primarily targets the oncology and inflammatory disease markets with its product offerings. The company's flagship product, UDENYCA, is a biosimilar to Neulasta, designed to stimulate the production of granulocytes to enhance the body’s infection-fighting capabilities. Coherus is also advancing several other biosimilar candidates, including those for Humira and Enbrel, which have completed Phase III clinical studies. Additionally, the company is working on biosimilars for other biologics, including ranibizumab and aflibercept, as well as a small-molecule drug for metabolic conditions. Coherus BioSciences was founded in 2010 and has established various license agreements to support its product development initiatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.